SIPNOSE

SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications. The company's flexible solution is suitable for clinical or home use, for daily or emergency administration, for pediatric, adult, and geriatric patients. The company's devices allows new treatments for a wide variety of neurological disorders. Founded in 2011, SipNose collaborates with worldwide pharmaceutical and biopharmaceutical companies. It is headquartered in Yoqne`am `illit, Israel.